Press release
Angina Pectoris Drugs Market Analysis, Business Development, Size, Forecast To 2033
Angina Pectoris Drugs Market Analysis
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=10797&type=smp
Surging Prevalence Of Chronic Angina Pectoris Propels Growth In The Angina Pectoris Drug Market
The increasing prevalence of chronic angina pectoris is expected to propel the growth of the angina pectoris drug market going forward. Chronic angina pectoris is chest pain or discomfort caused by reduced blood flow to the heart muscle. Angina pectoris drugs are vital in treating chronic angina. They can provide several benefits to those suffering from this illness, including coronary heart disease, cardiovascular disease, high blood pressure, and being overweight or obese. For instance, in May 2023, according to the Centers for Disease Control and Prevention Highlights, a US-based intergovernmental organization, coronary heart disease killed round 375,476 people in 2021 where, roughly one in every twenty people aged 20 and over (5%). Further, in 2021, almost 2 out of every 10 deaths from coronary artery disease are expected to occur in people under 65. Furthermore, in December 2022, according to the National Library of Medicine, a national center for biological information, Angina affects more than 10 million people in the United States, with more than 500,000 new diagnoses each year. Therefore, the increasing prevalence of chronic angina pectoris is driving the growth of the angina pectoris drug market.
Hikma Pharmaceuticals Unveils Labetalol Hydrochloride Injection, Usp, Marking A Milestone In Angina Pectoris Drug Market
Product innovation is a key trend gaining popularity in angina pectoris drugs market. Major companies operating in the angina pectoris drug market are adopting new technologies to sustain their position in the market. For instance, in March 2023, Hikma Pharmaceuticals plc, a UK-based pharmaceutical company, launched Labetalol Hydrochloride Injection, USP, in a prefilled syringe. The Food and Drug Administration of the United States has authorized this product. In hospitals, 10 mg/2 mL PFS is used to treat severe hypertension and lower blood pressure.
The angina pectoris drugs market covered in this report is segmented -
1) By Drugs: Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins, Antihypertensive Agents, Other Drugs
2) By Indication: Stable Angina, Unstable Angina, Prinzmetal's Angina
3) By Route of Administration: Oral, Parenteral, Transdermal, Other Route Of Administrations
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=10797&type=discount
Major companies operating in the angina pectoris drugs market report are Astellas Pharma Inc., Bayer AG, Novartis AG, AstraZeneca PLC, Amgen Inc., Gilead Sciences Inc., Bausch Health Companies Inc., Merck & Co Inc., Eli Lilly and Company, Otsuka Pharmaceutical Co Ltd., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, AbbVie Inc., Sun Pharmaceutical Industries Limited, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Sanofi SA, Sun BioPharma Inc., Atox Bio Inc., CalciMedica Inc., D-Pharm Ltd., Dynavax Technologies Corporation, Fresenius SE & Co KGaA, Olympus Corporation, SCM Lifescience Co. Ltd., Allergan plc, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Vertex Pharmaceuticals Incorporated, Johnson & Johnson,
Contents of the report:
1. Executive Summary
2. Angina Pectoris Drugs Market Report Structure
3. Angina Pectoris Drugs Market Trends And Strategies
4. Angina Pectoris Drugs Market - Macro Economic Scenario
5. Angina Pectoris Drugs Market Size And Growth
…..
27. Angina Pectoris Drugs Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Angina Pectoris Drugs Market Analysis, Business Development, Size, Forecast To 2033 here
News-ID: 3597011 • Views: …
More Releases from The Business research company
Design, Research, Promotional And Consulting Services Market Expansion Continues …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Design, Research, Promotional And Consulting Services Market Size Growth Forecast: What to Expect by 2025?
The market size of design, research, promotional and consulting services has seen consistent growth in the last few years. It's projected to elevate from $4526.88 billion in 2024 to $4746.82 billion in 2025, with…
Storage Area Network Market Expansion Continues, with Forecast Valuation of $46. …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Storage Area Network Industry Market Size Be by 2025?
In the past few years, we have seen significant and speedy growth in the storage area network market size. The market, which stands at $25.08 billion in 2024, is projected to increase to $28.44 billion in 2025,…
Online Legal Services Market Expansion Continues, with Forecast Valuation of $42 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Online Legal Services Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for online legal services has seen a swift expansion in the past years. A jump from $22.05 billion in 2024 to $25.24 billion in 2025, equating to a compound annual growth…
K-12 Private Education Market Expansion Continues, with Forecast Valuation of $6 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the K-12 Private Education Market Size By 2025?
The size of the K-12 private education sector has seen robust expansion in the recent past. From being a market worth $396.86 billion in 2024, it's projected to scale up to $431.46 billion in 2025, growing at a…
More Releases for Angina
Angina (Angina Pectoris) Pipeline: 10+ Companies Transforming Chest Pain Managem …
The angina therapeutics pipeline is experiencing a renaissance, driven by pharmaceutical companies such as Abbott Laboratories, AstraZeneca, Bayer AG, and Bristol-Myers Squibb. With a focus on improving myocardial efficiency and reducing ischemic burden, emerging therapies-including metabolic modulators, nitric oxide donors, and gene therapies-aim to offer more effective symptom relief and reduce cardiovascular events. Innovations are targeting both stable and microvascular angina forms, addressing the significant unmet needs in chronic angina…
Key Influencer in the Angina Pectoris Drugs Market Outlook 2025: Surging Prevale …
What market dynamics are playing a key role in accelerating the growth of the angina pectoris drugs market?
The surge in cardiovascular diseases is anticipated to kick-start the expansion of the angina pectoris drug market. The scope of cardiovascular diseases includes diverse disorders affecting the heart and blood vessels, such as stroke, coronary artery disease, hypertension, and heart failure. The rising prevalence of cardiovascular diseases (CVD) is linked to numerous elements,…
What's Driving the Angina Market 2025-2034: The Rising Prevalence of Coronary Ar …
What Are the Projections for the Size and Growth Rate of the Angina Market?
The scale of the angina market has seen robust growth in the previous years. The expansion is expected to continue, increasing from a value of $10.71 billion in 2024 to $11.4 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.4%. The surge in the past period can be credited to factors such as a…
Angina Pectoris - Drug Pipeline Landscape, 2022
Global Angina Pectoris Market report from Global Insight Services is the single authoritative source of intelligence on angina pectoris market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,…
Angina Pectoris - Drug Pipeline Landscape, 2022
Angina also known as angina pectoris, is a type of chest pain or discomfort that occurs when a part of the heart doesn't get enough blood and oxygen, which is due to the spasm or obstruction of the arteries that supply the blood to the heart muscles. Angina is mainly of four types: stable angina, unstable angina, microvascular angina, and vasospastic or variant angina.
Angina is caused due to the built…
Angina Pectoris Drugs Market Set for Rapid Growth
Global Angina Pectoris Drugs Market: Overview
The demand within the global market for angina pectoris drugs has been rising on account of the focus given on treating medical conditions suffered by the geriatric population. The presence of a seamless industry for healthcare diagnostic and treatment has played a major role in market growth. Angina pectoris is a type of chest pain that is triggered due to reduced blood flow to…
